Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system

Journal of Neuroimmunology

Volumn 270, Issue 1-2, 2014, Pages 98-99

  Tanaka, Masami ^a   Tanaka, Keiko ^b  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti myelin oligodendrocyte glycoprotein antibodies; Anti aquaporin 4 antibodies; Cell based immunofluorescence assay; Multiple sclerosis; Neuromyelitis optica; Optic neuritis

Indexed keywords

ANTI- MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES; ANTI-AQUAPORIN 4 ANTIBODIES; CELL-BASED IMMUNOFLUORESCENCE ASSAY; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NEURITIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MYELITIS, TRANSVERSE; OPTIC NEURITIS; YOUNG ADULT;

EID: 84898783632     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.03.001     Document Type: Article

References (17)

1. Bettelli E., Baeten D., Jäger A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006, 116:2393-2402.
2. Brilot F., Dale R.C., Selter R.C., Grummel V., Kalluri S.R., Aslam M., et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 2009, 66:833-842.
3. Hacohen Y., Absoud M., Woodhall M., Cummins C., De Goede C.G., Hemingway C., et al. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J. Neurol. Neurosurg. Psychiatry 2013, 85:456-461.
4. Huppke P., Rostasy K., Karenfort M., Huppke B., Seidl R., Leiz S., et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult. Scler. 2013, 19:941-946.
5. Kitley J., Woodhall M., Waters P., Leite M.I., Devenney E., Craig J., et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012, 79:1273-1277.
6. Kitley J., Leite M.I., Küker W., Quaghebeur G., George J., Waters P., et al. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol. 2013, 70:1375-1381.
7. Krishnamoorthy G., Lassmann H., Wekerle H., Holz A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 2006, 116:2385-2392.
8. Mader S., Gredler V., Schanda K., Rostasy K., Dujmovic I., Pfaller K., et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J. Neuroinflammation 2011, 8:184.
9. Mayer M.C., Meinl E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther. Adv. Neurol. Disord. 2012, 5:147-159.
10. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
11. Pröbstel A.K., Dornmair K., Bittner R., Sperl P., Jenne D., Magalhaes S., et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011, 77:580-588.
12. Reindl M., Di Pauli F., Rostásy K., Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat. Rev. Neurol. 2013, 9:455-461.
13. Rostasy K., Mader S., Schanda K., Huppke P., Gärtner J., Kraus V., et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch. Neurol. 2012, 69:752-756.
14. Rostásy K., Mader S., Hennes E.M., Schanda K., Gredler V., Guenther A., et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult. Scler. 2013, 19:1052-1059.
15. Tanaka K., Tani T., Tanaka M., Saida T., Idezuka J., Yamazaki M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult. Scler. 2007, 13:850-855.
16. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
17. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.